Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ. Brousseau ME, et al. Among authors: rubins hb. Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1148-54. doi: 10.1161/01.atv.0000024566.57589.2e. Arterioscler Thromb Vasc Biol. 2002. PMID: 12117730 Clinical Trial.
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial.
Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, McNamara JR, Kashyap ML, Hershman JM, Wexler LF, Rubins HB; VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial. Robins SJ, et al. Among authors: rubins hb. JAMA. 2001 Mar 28;285(12):1585-91. doi: 10.1001/jama.285.12.1585. JAMA. 2001. PMID: 11268266 Clinical Trial.
Conclusions from the VA-HIT study.
Rubins HB, Robins SJ. Rubins HB, et al. Am J Cardiol. 2000 Sep 1;86(5):543-4. doi: 10.1016/s0002-9149(00)01010-9. Am J Cardiol. 2000. PMID: 11009274 No abstract available.
38 results